<DOC>
	<DOCNO>NCT00031304</DOCNO>
	<brief_summary>Healthy volunteer screen protocol possible participation study test vaccine HIV , virus cause AIDS . Healthy adults 18 60 year age may eligible study . Participants must good general health history significant medical problem abnormal laboratory test result . Pregnant breast-feeding woman people infect HIV enrol . Participants enrol protocol undergo follow test procedure within 8 week start experimental vaccine study : - Medical history , include history sexual activity drug use - Physical examination - Pregnancy test woman childbearing age - Blood urine test evaluate possible medical problem liver kidney function ; evaluate immune function ; test HIV , hepatitis syphilis Individuals identify screen protocol possible candidate HIV vaccine trial provide additional information study option .</brief_summary>
	<brief_title>Screening Protocol HIV Vaccine Studies</brief_title>
	<detailed_description>Study Design : The purpose study screen subject determine suitable candidate HIV vaccine trial . Healthy , HIV-negative subject recruit screen . The result study used determine subject meet eligibility requirement participation H1V vaccine trial . Educational material vaccine review provided subject enrollment study . Subjects : Healthy adult Number Subjects : Approximately 3,000 Outline Protocol : There one visit evaluate subject eligibility HIV vaccine trial . The evaluation usually include laboratory study , physical assessment , counsel avoidance HIV infection , pregnancy HIV-related issue . Only evaluation need determine eligibility particular study do . Evaluations blood urine sample describe protocol may do necessary eligibility study . If determine subject might eligible HIV vaccine trial , subject receive additional information trial option telephone , mail and/or visit study coordinator . Several visit may occur need confirm eligibility participation vaccine clinical trial . Study Duration : Varies 2 week six month subject Monitoring Trial : Principal Investigator designate staff Vaccine Research Center Regulatory , Affairs Clinical Trials Core Sponsoring Agency : Vaccine Research Center ( VRC ) , National Institute Allergy Infectious Diseases ( NIAID ) , NIH Clinical Sites : NIH Clinical Center [ include satellite location VRC Mobile Clinical Trials Unit ( MCTU ) VRC Clinic Cedar Lane ] IRB-approved extramural site Principal Investigator : Barney S. Graham , M.D. , Ph.D. , VRC/NIAID/NIH</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>INCLUSION CRITERIA : Age : 1860 year age . Available participate plan duration investigational vaccine study screen do ( vaccine study may require 6 month 18 month clinic visit ) . Able willing complete inform consent process . Agree blood store future study vaccine , immune system , and/or medical condition . EXCLUSION CRITERIA : Known HIV infect . Women know pregnant and/or breast feeding . A condition repeat blood draw injection pose minimal risk subject hemophilia , severe coagulation disorder significantly impair venous access . A condition require active medical intervention monitoring avert serious danger participant 's health wellbeing .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 8, 2013</verification_date>
	<keyword>HIV</keyword>
	<keyword>AIDS</keyword>
	<keyword>Vaccine</keyword>
	<keyword>Screening</keyword>
	<keyword>Prevention</keyword>
	<keyword>HV</keyword>
	<keyword>Healthy Volunteer</keyword>
	<keyword>Volunteer</keyword>
	<keyword>HIV Seronegativity</keyword>
	<keyword>HIV Preventive Vaccine</keyword>
</DOC>